Does Rallies show Form 4 insider transactions for SER?

Yes. Rallies tracks SER insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SER research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SER. It does not provide personalized investment advice.

SER (Serina Therapeutics, Inc.) Stock Analysis - Insider Trades

Serina Therapeutics, Inc. (SER) is a publicly traded Healthcare sector company. As of May 21, 2026, SER trades at $1.71 with a market cap of $22.65M and a P/E ratio of -0.90. SER moved +5.59% today. Year to date, SER is -18.27%; over the trailing twelve months it is -70.23%. Its 52-week range spans $1.22 to $8.14. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces SER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SER stock inside the company?

Recent SER insider activity includes Moreadith Randall sold 6.50K, Moreadith Randall sold 39.00K, Moreadith Randall sold 6.50K, Moreadith Randall sold 6.50K, and Moreadith Randall sold 2.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SER Key Metrics

Key financial metrics for SER
Metric	Value
Price	$1.71
Market Cap	$22.65M
P/E Ratio	-0.90
EPS	$-1.91
Dividend Yield	0.00%
52-Week High	$8.14
52-Week Low	$1.22
Volume	91
Avg Volume	0
Revenue (TTM)	$130.00K
Net Income	$-19.21M
Gross Margin	0.00%

Recent SER Insider Trades

Moreadith Randall sold 6.50K (~$18.57K) on Mar 23, 2026.
Moreadith Randall sold 39.00K (~$97.50K) on Mar 19, 2026.
Moreadith Randall sold 6.50K (~$19.68K) on Feb 2, 2026.
Moreadith Randall sold 6.50K (~$23.19K) on Jan 28, 2026.
Moreadith Randall sold 2.50K (~$7.38K) on Jan 22, 2026.

Latest SER News

Serina Therapeutics Secures $21.2M Financing, Advances SER-252 Phase 1b Parkinson’s Trial — May 14, 2026
Serina Granted Until July 9, 2027 to Restore NYSE Listing Compliance — Apr 2, 2026
Serina Therapeutics Secures FDA IND Clearance, Doses First Patient, Raises $16M — Mar 25, 2026

SER Analyst Consensus

1 analysts cover SER: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.

Common questions about SER

Who is trading SER stock inside the company?: Recent SER insider activity includes Moreadith Randall sold 6.50K, Moreadith Randall sold 39.00K, Moreadith Randall sold 6.50K, Moreadith Randall sold 6.50K, and Moreadith Randall sold 2.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SER?: Yes. Rallies tracks SER insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SER research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SER. It does not provide personalized investment advice.